Skip to main content
Premium Trial:

Request an Annual Quote

Genomenon Enters Chinese Market With Shanghai Shanyi Partnership

NEW YORK – Genomenon has entered the Chinese market by forming a partnership with Shanghai Shanyi Biological Technology Co., a provider of sequencing interpretation, variant validation, and other molecular technology services. 

Ann Arbor, Michigan-based Genomenon said today that the new partnership will allow the company to bring its Mastermind genomic search engine to clinical laboratories in China. 

"Our partnership with Shanghai Shanyi will allow us to expand our footprint in the China market, seamlessly integrating with their other best-of-breed end-to-end clinical [next-generation sequencing] solutions," Genomenon CEO Mike Klein said in a statement.

"We’re proud to bring Mastermind to clinical laboratories in China," added Lei Li, general manager of Shanghai Shanyi. Shanyi said that early work with Genomenon has helped customers reduce the amount of time they spend searching for variants of unknown significance by 60 percent to 80 percent.

Genomenon previously operated only in North America and Europe, through partnerships with the likes of US-based LifeMap Sciences, Parabricks, Belgian artificial intelligence vendor Diploid, and others. 

The company raised $2.5 million in private equity early this year.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.